Source: Sharecast
GSK gained as it entered into a partnership with Chinese pharmaceutical outfit Hengrui Pharma to jointly develop up to 12 medicines, in a deal that could be worth up to $12bn.
The pharmaceuticals group said in a statement that the agreement provides it with new growth opportunities beyond 2031.
BT Group was the biggest loser on the index, having surged last Thursday on the back of a trading statement in which it hailed a "solid" start to the year.
FTSE 100 - Risers
Smurfit Westrock (DI) (SWR) 3,648.00p 2.30%
Flutter Entertainment (DI) (FLTR) 22,740.00p 1.70%
Rightmove (RMV) 792.40p 1.54%
CRH (CDI) (CRH) 7,446.00p 1.39%
Intertek Group (ITRK) 4,966.00p 1.10%
Barclays (BARC) 364.20p 1.03%
BP (BP.) 401.50p 0.93%
Reckitt Benckiser Group (RKT) 5,628.00p 0.79%
Land Securities Group (LAND) 589.00p 0.77%
GSK (GSK) 1,403.00p 0.75%
FTSE 100 - Fallers
BT Group (BT.A) 212.60p -4.54%
Marks & Spencer Group (MKS) 346.80p -2.31%
Vodafone Group (VOD) 83.24p -2.14%
Glencore (GLEN) 311.75p -2.04%
Babcock International Group (BAB) 1,022.00p -2.01%
Diageo (DGE) 1,941.50p -1.75%
Centrica (CNA) 160.10p -1.63%
Rio Tinto (RIO) 4,604.00p -1.62%
Taylor Wimpey (TW.) 108.95p -1.58%
Kingfisher (KGF) 274.70p -1.51%